Buyalos R P, Funari V A, Azziz R, Watson J M, Martinez-Maza O
University of California, Los Angeles (UCLA) Medical Center.
Fertil Steril. 1992 Aug;58(2):302-6.
To determine if interleukin 6 (IL-6) is a normal constituent of peritoneal fluid (PF), and if various types of pelvic pathology influence its presence within the PF microenvironment.
Peritoneal fluid from 73 women obtained at the time of laparoscopy was examined for the presence of IL-6 using an IL-6 specific sandwich enzyme-linked immunosorbent assay. Thirty-nine patients had pelvic endometriosis, 17 had nonendometriotic pelvic adhesive disease, and 17 subjects undergoing tubal sterilization without evidence of pelvic pathology served as controls.
Immunoreactive IL-6 was observed in the PF of all 73 subjects (range 0.26 to 11.16 ng/mL). The mean concentration of IL-6 was higher in women with nonendometriotic pelvic adhesions as compared with control subjects (1.28 +/- 0.16 versus 0.80 +/- 0.06 ng/mL, P less than 0.03). There was no difference in the mean peritoneal concentrations of IL-6 between women with endometriosis (1.16 +/- 0.28 ng/mL) and controls, P = 0.38. Twenty-seven of 73 patients (37%) demonstrated elevated levels (greater than 1.0 ng/mL) of IL-6. Patients with pelvic adhesions were significantly more likely to have elevated concentrations of IL-6 than controls (10/17 [59%] versus 3/17 [18%], P less than 0.02). Alternatively, the percentage of patients with elevated IL-6 concentrations did not differ between patients with endometriosis or controls (14/39 [36%] versus 3/17 [18%], P greater than 0.10).
These findings demonstrate that IL-6 is a normal constituent of PF and that elevated levels are found in many patients with pelvic adhesions.
确定白细胞介素6(IL-6)是否为腹腔液(PF)的正常成分,以及各种类型的盆腔病变是否会影响其在PF微环境中的存在。
在腹腔镜检查时从73名女性获取腹腔液,使用IL-6特异性夹心酶联免疫吸附测定法检测IL-6的存在。39例患者患有盆腔子宫内膜异位症,17例患有非子宫内膜异位性盆腔粘连疾病,17例接受输卵管绝育且无盆腔病变证据的受试者作为对照。
在所有73名受试者的PF中均观察到免疫反应性IL-6(范围为0.26至11.16 ng/mL)。与对照受试者相比,非子宫内膜异位性盆腔粘连女性的IL-6平均浓度更高(1.28±0.16对0.80±0.06 ng/mL,P<0.03)。子宫内膜异位症女性与对照组之间的IL-6平均腹腔浓度无差异(1.16±0.28 ng/mL),P = 0.38。73例患者中有27例(37%)IL-6水平升高(>1.0 ng/mL)。盆腔粘连患者IL-6浓度升高的可能性明显高于对照组(10/17 [59%]对3/17 [18%],P<0.02)。另外,子宫内膜异位症患者或对照组中IL-6浓度升高的患者百分比无差异(14/39 [36%]对3/17 [18%],P>0.10)。
这些发现表明IL-6是PF的正常成分,并且在许多盆腔粘连患者中发现其水平升高。